A Phase I Trial to Determine the Safety and Tolerability of Autophagy Inhibition Using Chloroquine or Hydroxychloroquine in Combination With Carboplatin and Gemcitabine in Patients With Advanced…

Overview of attention for article published in Frontiers in oncology, April 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 3 X users

peer_reviews: 1 peer review site

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 2 Mendeley

Summary X Peer reviews Dimensions citations

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 8,853 followers.

RT @FrontOncology: New research: A Phase I Trial to Determine the Safety and Tolerability of Autophagy Inhibition Using Chloroquine or Hydr…

09 May 2022

Reply Repost Favourite

RT @NaglaAKarimMD: Thank you to my mentors, colleagues and patients who supported the success of my clinical trials.

03 May 2022

Reply Repost Favourite

Thank you to my mentors, colleagues and patients who supported the success of my clinical trials.

01 May 2022

Reply Repost Favourite

📄 New article: A Phase I Trial to Determine the Safety and Tolerability of Autophagy Inhibition Using Chloroquine or Hydroxychloroquine in Combination With Carboplatin and Gemcitabine 👨‍⚕️👩‍⚕️ @NaglaAKarimMD et al. Read 👉 https://t.co/WiXziSGJg6 @AUG_Un

01 May 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.